Description
Fulvestrant, marketed under the brand name FASLODEX, It is an prescription medication that has been approved fulvestrant (Faslodex) on April 25, 2002 for the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women.
What is FASLODEX (fulvestrant) ?
FASLODEX is an estrogen receptor antagonist indicated for the: • Treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.
Quote From FDA
How to order approved “FASLODEX (fulvestrant) for Injection” Medicine?
FASLODEX (Fulvestrant) Injection is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing FASLODEX and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.





